Immunosuppressive therapy must be guided by therapeutic drug monitoring (TDM) in paediatric liver (LT) and kidney transplantation (KT) patients to prevent under- and overdosing, which have clinical consequences
Adequate immunosuppression minimising the risk of organ rejection with acceptable tolerability of th...
Immunosuppressive therapy is the most crucial treatment of organ-transplanted patients. Both cyclosp...
OBJECTIVE: To determine the relation between tacrolimus trough levels in blood and adverse events in...
Immunosuppressive therapy must be guided by therapeutic drug monitoring (TDM) in paediatric liver (L...
The regulation of the immunosuppressive therapy after kidney transplantation is the most complex asp...
Background: Therapeutic drug monitoring (TDM) in patients with Chronic Kidney Disease (CKD) with kid...
Immunosuppressive drugs play a crucial role in the inhibition of immune reaction and prevention of g...
The emergence of specific immunosuppressive drugs (cyclosporine, tacrolimus, mycophenolate mofetil a...
Immunosuppressive drugs (IS) used in solid organ transplantation are critical dose drugs with high i...
The pharmacokinetics of drugs, such as immunosuppressants, justify the need of measuring their blood...
Antiretroviral (ARV) drug interactions in HIV-infected liver transplant (LTx) recipients can lead t...
The major advance allowing prolonged graft survival has been the use of immunosuppressive drugs that...
The pharmacokinetics of drugs, such as immunosuppressants, justify the need of measuring their blood...
Immunosuppressants require therapeutic drug monitoring because of their narrow therapeutic index and...
Immunosuppressive medicines are characterized by specific pharmacokinetic profile which requires the...
Adequate immunosuppression minimising the risk of organ rejection with acceptable tolerability of th...
Immunosuppressive therapy is the most crucial treatment of organ-transplanted patients. Both cyclosp...
OBJECTIVE: To determine the relation between tacrolimus trough levels in blood and adverse events in...
Immunosuppressive therapy must be guided by therapeutic drug monitoring (TDM) in paediatric liver (L...
The regulation of the immunosuppressive therapy after kidney transplantation is the most complex asp...
Background: Therapeutic drug monitoring (TDM) in patients with Chronic Kidney Disease (CKD) with kid...
Immunosuppressive drugs play a crucial role in the inhibition of immune reaction and prevention of g...
The emergence of specific immunosuppressive drugs (cyclosporine, tacrolimus, mycophenolate mofetil a...
Immunosuppressive drugs (IS) used in solid organ transplantation are critical dose drugs with high i...
The pharmacokinetics of drugs, such as immunosuppressants, justify the need of measuring their blood...
Antiretroviral (ARV) drug interactions in HIV-infected liver transplant (LTx) recipients can lead t...
The major advance allowing prolonged graft survival has been the use of immunosuppressive drugs that...
The pharmacokinetics of drugs, such as immunosuppressants, justify the need of measuring their blood...
Immunosuppressants require therapeutic drug monitoring because of their narrow therapeutic index and...
Immunosuppressive medicines are characterized by specific pharmacokinetic profile which requires the...
Adequate immunosuppression minimising the risk of organ rejection with acceptable tolerability of th...
Immunosuppressive therapy is the most crucial treatment of organ-transplanted patients. Both cyclosp...
OBJECTIVE: To determine the relation between tacrolimus trough levels in blood and adverse events in...